Optimal duration of dual antiplatelet therapy after drug eluting stent remains unclearBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2841 (Published 26 May 2015) Cite this as: BMJ 2015;350:h2841
- Susan Mayor
Longer duration of dual antiplatelet therapy after implantation of a drug eluting stent is associated with fewer myocardial infarctions but more major bleeding than a shorter duration, a systematic review has found.
Current guidelines recommend six or 12 months of treatment with aspirin plus a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) to reduce the risk of stent thrombosis. But the optimal duration of therapy …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial